Induction of autoantibodies to murine P-glycoprotein: Consequences on drug sensitivity in MDR cancer cells and on the expression of mdr genes in organs

Biochemical and Biophysical Research Communications

Volumn 358, Issue 1, 2007, Pages 325-330

  Perrin, Laura ^a   Gatouillat, Grégory ^a   Balasse, Emilie ^a   Odot, Johann ^a   Nicolau, Claude ^b   Tosi, Pierre François ^a   Madoulet, Claudie ^a  

^a Laboratory of Biochemistry   (France)

^b AC IMMUNE SA   (Switzerland)

Author keywords

Autoantibodies; Multidrug resistance; P glycoprotein; Peptides; Vaccination

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AUTOANTIBODY; DOXORUBICIN; GLYCOPROTEIN P; IMMUNOGLOBULIN G; LIPOPEPTIDE; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN 1; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; AUTOANTIBODIES; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, MDR; LIPOSOMES; MICE; ORGAN SPECIFICITY; P-GLYCOPROTEIN; P-GLYCOPROTEINS; PEPTIDES; VINBLASTINE;

MURINAE; MUS;

EID: 34248223807     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.117     Document Type: Article

References (23)

1. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., and Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 361-398
2. Endicott J.A., and Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58 (1989) 137-171
3. Gros P., Ben Neriah Y.B., Croop J.M., and Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323 (1986) 728-731
4. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40 Suppl. (1997) S3-S8
5. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., and Willingham W.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84 (1987) 7735-7738
6. Gros P.H., Croop J., and Houseman D. Mammalian drug resistance gene: complete cDNA sequence indicates a strong homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells. Cell 47 (1986) 371-380
7. Devault A., and Gros P. Two members of the mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10 (1990) 1652-1663
8. Ruetz S., and Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77 (1994) 1071-1081
9. Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., and Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38 (1990) 1277-1287
10. Pawlak-Roblin C., Tosi P.F., Perrin L., Devy J., Ventéo L., Albert P., Nicolau C., and Madoulet C. Inhibition of multidrug resistance by immunisation with synthetic P-glycoprotein-derived peptides. Eur. J. Cancer 40 (2004) 606-613
11. Tosi P.F., Radu D., and Nicolau C. Immune response against the murine mdr1 protein induced by vaccination with lipopeptides in liposomes. Biochem. Biophys. Res. Com. 212 (1995) 494-500
12. Germann U.A. P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32A (1996) 927-944
13. Tsuruo T., Iida H., Tsukagoshi S., and Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41 (1981) 1967-1972
14. Egashira M., Kawamata N., Sugimoto K., Kaneko T., and Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93 (1999) 599-606
15. Figueredo A., Arnold A., Goodyear M., Findlay B., Neville A., Normandeau R., and Jones A. Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study. Cancer 65 (1990) 1895-1902
16. Hamada H., and Tsuruo T. Functional role for the 170- to 180 kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 83 (1986) 7785-7789
17. Mickisch G.H., Pai L.H., Gottesman M.M., and Pastan I. Monoclonal antibodies MRK16 reverses the multidrug resistance of multidrug-resistance transgenic mice. Cancer Res. 52 (1992) 4427-4432
18. Mechetner E.B., and Roninson I.B. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA 89 (1992) 5824-5828
19. Schinkel A.H., Borst P., Smit J.J.M., Wagenaar E., Dollé M., Arceci R.J., Baas F., Tsuruo T., Mechetner E.B., and Roninson I.B. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int. J. Cancer 55 (1993) 478-484
20. Brock I., Hipfner D.R., Nielsen B.S., Jensen P.B., Deeley R.G., Cole S.P., and Sehested M. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res. 55 (1995) 459-462
21. Kutlik M.T., Ayhan A., Gogus S., Yalcin B., Caglar M., and Buyukpamukcu M. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma. Pediatr. Hematol. Oncol. 19 (2002) 337-345
22. Valtulini S., Macchi C., Ballanti P., Cherel Y., Laval A., Theaker J.M., Bake M., Ferretti E., and Morvan H. Aluminium hydroxide-induced granulomas in pigs. Vaccine 23 (2005) 3999-4004
23. Bordet A.L., Michenet P., Cohen C., Ekindi N., Bonneau C., Kerdraon R., and Coville M. Post-vaccination granuloma due to aluminium hydroxide. Ann. Pathol. 21 (2001) 149-152